chlormadinone acetate has been researched along with leuprolide in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.00) | 18.7374 |
| 1990's | 5 (25.00) | 18.2507 |
| 2000's | 12 (60.00) | 29.6817 |
| 2010's | 2 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikemoto, I; Machida, T | 1 |
| Akaza, H; Aso, Y; Hirao, Y; Homma, Y; Moriyama, N; Ohashi, Y; Okada, K; Sakamoto, A; Tsushima, T; Usami, M; Yokoyama, M | 3 |
| Hirao, Y; Ozono, S | 1 |
| Fuji, K; Hamajima, T; Higaki, Y; Hiramori, M; Hoshino, M; Ikeuchi, T; Inoue, K; Kai, Y; Kasahara, T; Matsuda, N; Ogawa, Y; Shimada, M; Uchida, H; Yoshida, H | 1 |
| Honda, M; Hosoya, Y; Kitahara, S; Koga, F; Moriguchi, H; Sumi, S; Umeda, H; Yano, M; Yoshida, K | 1 |
| Akaza, H; Aso, Y; Hirao, Y; Homma, Y; Moriyama, N; Ohashi, Y; Okada, K; Tsushima, T; Usami, M; Yokoyama, M | 1 |
| Harada, M; Hosaka, M; Kawasaki, C; Kinoshita, Y; Kondo, I; Miura, T; Noguchi, K; Ohuchi, H | 1 |
| Kiriyama, I; Nishimura, T; Ogaki, K; Ohba, S | 1 |
| Mizokami, A; Namiki, M | 1 |
| Akaza, H; Gotanda, K; Hagiwara, M; Kobayashi, H; Nakano, Y; Okada, M; Sasaki, T; Shinbo, A | 1 |
| Akaza, H; Aso, Y; Hirao, Y; Homma, Y; Ohashi, Y; Okada, K; Sakamoto, A; Tsushima, T; Usami, M; Yokoyama, M | 1 |
| Kondo, Y; Kunimoto, K; Nishimura, T; Saito, Y; Shimizu, H | 1 |
| Fujimoto, H; Fukui, I; Harada, M; Ito, K; Kakizoe, T; Kotake, T; Matsuoka, N; Naito, S; Ohashi, Y; Tsukamoto, T; Usami, M; Yamanaka, H | 1 |
| Kobayashi, M; Morita, T; Nukui, A | 1 |
| Akaza, H | 1 |
| Hakariya, H; Hara, T; Hayashi, M; Igawa, T; Iwasaki, S; Kanetake, H; Kusaba, Y; Sakai, H; Tsurusaki, T; Yura, M | 1 |
| Kobayashi, M; Kurokawa, S; Morita, T; Nukui, A; Suzuki, K | 1 |
| Amao, R; Goto, J; Haga, N; Ichikawa, Y; Maeno, T; Ohtsu, H; Taguri, M; Tsuji, S; Yamamoto, T; Yokota, K | 1 |
3 review(s) available for chlormadinone acetate and leuprolide
| Article | Year |
|---|---|
[Total androgen blockade--concept, theory, method and clinical application].
Topics: Androgen Antagonists; Antineoplastic Agents, Hormonal; Chlormadinone Acetate; Flutamide; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Neoplasms, Hormone-Dependent; Orchiectomy; Prostatic Neoplasms | 1998 |
[Total androgen blockade].
Topics: Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Castration; Chlormadinone Acetate; Drug Therapy, Combination; Flutamide; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Nitriles; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Tosyl Compounds | 2002 |
Global update on defining and treating high-risk localized prostate cancer with leuprorelin: a Japanese perspective--the effect of primary androgen deprivation therapy on stage C prostate cancer.
Topics: Aged; Androgen Antagonists; Anilides; Antineoplastic Combined Chemotherapy Protocols; Chlormadinone Acetate; Gonadotropin-Releasing Hormone; Humans; Japan; Leuprolide; Male; Neoplasm Staging; Nitriles; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Tosyl Compounds | 2007 |
10 trial(s) available for chlormadinone acetate and leuprolide
| Article | Year |
|---|---|
Preoperative endocrine therapy for clinical stage A2, B, and C prostate cancer: an interim report on short-term effects. Prostate Cancer Study Group.
Topics: Aged; Antineoplastic Agents, Hormonal; Chlormadinone Acetate; Humans; Leuprolide; Lymph Node Excision; Male; Multivariate Analysis; Neoplasm Staging; Preoperative Care; Progesterone Congeners; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Time Factors; Treatment Outcome | 1997 |
[Clinical study on chlormadinone acetate alone followed by combination with LH-RH analogue for prostatic cancer: effects on lipid metabolism].
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Apolipoproteins; Chlormadinone Acetate; Cholesterol; Drug Administration Schedule; Drug Therapy, Combination; Humans; Leuprolide; Lipid Metabolism; Male; Middle Aged; Progesterone Congeners; Prostate-Specific Antigen; Prostatic Neoplasms; Testosterone; Triglycerides | 1998 |
Early results of radical prostatectomy and adjuvant endocrine therapy for prostate cancer with or without preoperative androgen deprivation. The Prostate Cancer Study Group.
Topics: Aged; Aged, 80 and over; Androgens; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Chlormadinone Acetate; Disease-Free Survival; Drug Therapy, Combination; Follow-Up Studies; Humans; Leuprolide; Male; Middle Aged; Neoplasm Recurrence, Local; Preoperative Care; Progesterone Congeners; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Retrospective Studies; Treatment Outcome | 1999 |
Early results of LH-RH agonist treatment with or without chlormadinone acetate for hormone therapy of naive localized or locally advanced prostate cancer: a prospective and randomized study. The Prostate Cancer Study Group.
Topics: Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Chlormadinone Acetate; Disease-Free Survival; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Male; Prospective Studies; Prostatic Neoplasms | 2000 |
Inhibition of disease flare with diethylstilbestrol diphosphate and chlormadinone acetate administration for two weeks prior to slow-releasing leuprolide acetate in prostatic cancer patients.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Autacoids; Chlormadinone Acetate; Diethylstilbestrol; Humans; Leuprolide; Luteinizing Hormone; Male; Middle Aged; Neoplasm Recurrence, Local; Premedication; Progesterone Congeners; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Testosterone | 2000 |
Endocrine therapy with or without radical prostatectomy for T1b-T3N0M0 prostate cancer.
Topics: Age Factors; Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Chlormadinone Acetate; Humans; Leuprolide; Male; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Retrospective Studies; Survival Rate | 2004 |
Radical prostatectomy and adjuvant endocrine therapy for prostate cancer with or without preoperative androgen deprivation: Five-year results.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Chlormadinone Acetate; Disease-Free Survival; Drug Therapy, Combination; Humans; Leuprolide; Male; Middle Aged; Neoplasm Recurrence, Local; Preoperative Care; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Treatment Outcome | 2004 |
Effectiveness of adjuvant intermittent endocrine therapy following neoadjuvant endocrine therapy and external beam radiation therapy in men with locally advanced prostate cancer.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Brachytherapy; Chlormadinone Acetate; Combined Modality Therapy; Disease-Free Survival; Humans; Leuprolide; Male; Middle Aged; Prostatic Neoplasms; Treatment Outcome | 2005 |
Hot flashes during androgen deprivation therapy with luteinizing hormone-releasing hormone agonist combined with steroidal or nonsteroidal antiandrogen for prostate cancer.
Topics: Aged; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Chlormadinone Acetate; Drug Therapy, Combination; Gonadotropin-Releasing Hormone; Hot Flashes; Humans; Leuprolide; Male; Nitriles; Prospective Studies; Prostatic Neoplasms; Quality of Life; Steroids; Tosyl Compounds | 2009 |
An open trial of long-term testosterone suppression in spinal and bulbar muscular atrophy.
Topics: Adult; Androgen Antagonists; Chlormadinone Acetate; Delayed-Action Preparations; Disease Progression; Humans; Knee; Leuprolide; Longitudinal Studies; Male; Middle Aged; Muscle Strength; Muscle Weakness; Muscular Disorders, Atrophic; Prospective Studies; Treatment Outcome | 2013 |
7 other study(ies) available for chlormadinone acetate and leuprolide
| Article | Year |
|---|---|
[Hormone therapy of male genital cancer (prostatic cancer)].
Topics: Buserelin; Chlormadinone Acetate; Estramustine; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Nitrogen Mustard Compounds; Prostatic Neoplasms | 1987 |
Effects of intravenous administration of high dose-diethylstilbestrol diphosphate on serum hormonal levels in patients with hormone-refractory prostate cancer.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents; Chlormadinone Acetate; Dehydroepiandrosterone Sulfate; Diethylstilbestrol; Drug Resistance, Neoplasm; Estradiol; Follicle Stimulating Hormone; Goserelin; Hormones; Humans; Hydrocortisone; Leuprolide; Male; Middle Aged; Progesterone Congeners; Prostatic Neoplasms; Sex Hormone-Binding Globulin; Testosterone | 1999 |
Neoadjuvant hormonal therapy prior to radical prostatectomy: evaluation of pathological downstaging and biochemical relapse.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Chlormadinone Acetate; Flutamide; Humans; Leuprolide; Male; Middle Aged; Neoadjuvant Therapy; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms | 2002 |
Effects of combination therapy with a luteinizing hormone-releasing hormone agonist and chlormadinone acetate on rat prostate weight and plasma testosterone levels.
Topics: Androgen Antagonists; Animals; Antineoplastic Agents, Hormonal; Chlormadinone Acetate; Dose-Response Relationship, Drug; Drug Therapy, Combination; Follicle Stimulating Hormone; Leuprolide; Luteinizing Hormone; Male; Orchiectomy; Organ Size; Prostate; Rats; Rats, Sprague-Dawley; Seminal Vesicles; Testosterone | 2003 |
Intracranial metastatic prostate carcinoma presenting as intermittent double vision.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Hormonal; Chlormadinone Acetate; Diplopia; Humans; Leuprolide; Magnetic Resonance Angiography; Male; Pituitary Neoplasms; Prostatic Neoplasms; Remission Induction | 2004 |
Pure red cell aplasia in a prostate cancer patient treated with leuprolide acetate and chlormadinone acetate.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Chlormadinone Acetate; Drug Therapy, Combination; Erythrocyte Transfusion; Humans; Leuprolide; Male; Prostatic Neoplasms; Radiotherapy, Adjuvant; Red-Cell Aplasia, Pure | 2005 |
Clinical efficacy of primary combined androgen blockade for Japanese men with clinically localized prostate cancer unsuitable for local definitive treatment: a single institution experience.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Androgens; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chlormadinone Acetate; Disease-Free Survival; Flutamide; Follow-Up Studies; Goserelin; Humans; Japan; Kaplan-Meier Estimate; Leuprolide; Male; Middle Aged; Neoplasm Staging; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Retrospective Studies; Tosyl Compounds; Treatment Outcome | 2011 |